Furthermore RT can induce PD-L1 expression on both tumor cells and immune cells as well as upregulation of immune checkpoint receptors (TIGIT, TIM3 ...) on tumor infiltrative lymphocytes, hence limiting the anti-tumor immunity [13–17]. The gene discussed is TIGIT; the disease is neoplasm.